Skip to main content
SpringerLink
Log in

iTRAQ-based quantitative proteomic analysis of esophageal squamous cell carcinoma

  • Original Article
  • Published:
Tumor Biology

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers. In this study, our objective was to identify differentially regulated proteins in ESCC using isobaric tag for relative and absolute quantification (iTRAQ) technique and liquid chromatography–tandem mass spectrometry (LC–MS/MS). We compared the protein expression profiles of ESCC tumor tissues with the corresponding adjacent normal tissue from three patients. It was determined that 72 and 57 unique proteins were significantly up-regulated and down-regulated in all three samples. In addition, there were 431 significantly differentially regulated proteins having at least two biological samples. This subject found some of the differential proteins, such as prolyl 4-hydroxylase subunit alpha-1, prolyl 4-hydroxylase subunit alpha-2, and calponin-2, immunoglobulin superfamily containing leucine-rich repeat protein, and prolyl 3-hydroxylase1, which were few studies about them in ESCC. In order to determine the results, we performed another independent experiment. Our results indicated quantitative proteomics, as a robust discovery tool for the identification, differentially regulated proteins in cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  2. Zhang P, Xi M, Li Q-Q, He L-R, Liu S-L, Zhao L, et al. The modified Glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy. J Cancer. 2014;5(8):689–95.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Keszei AP, Alexandra Goldbohm R, Schouten LJ, Jakszyn P, van den Brandt PA. Dietary N-nitroso compounds, endogenous nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands. Am J Clin Nutr. 2013;97(1):135–46.

    Article  CAS  PubMed  Google Scholar 

  4. D’Journo XB, Thomas PA. Current management of esophageal cancer. J Thorac Dis. 2014;6 Suppl 2:S253–64.

    PubMed  PubMed Central  Google Scholar 

  5. Guo X, Hao Y, Kamilijiang M, Hasimu A, Yuan J, Wu G, et al. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and ingenuity pathway analysis. Tumour Biol. 2015;36(3):1711–20.

    Article  CAS  PubMed  Google Scholar 

  6. Atrih A, Mudaliar MA, Zakikhani P, Lamont DJ, Huang JT, Bray SE, et al. Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling. Br J Cancer. 2014;110(6):1622–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gan CS, Chong PK, et al. Technical, experimental, and biological variations in isobaric tags for relatives and absolute quantitation (iTRAQ). J Proteome Res. 2007;6(2):821–7.

    Article  CAS  PubMed  Google Scholar 

  8. Gilmore JM, Washburn MP. Advances in shotgun proteomics and the analysis of membrane proteomes. J Proteomics. 2010;73(11):2078–91.

    Article  CAS  PubMed  Google Scholar 

  9. Xiao Z, Li G, Chen Y, Li M, Peng F, et al. Quantitative proteomic analysis of formalin-fixed and paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling, two-dimensional liquid chromatography and tandem mass spectrometry. J Histochem Cytochem. 2010;58(6):517–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Finn RD, Marshall M, Bateman A. Pfam: visualization of protein–protein interactions in PDB at domain and amino acid resolutions. Bioinformatics. 2005;21(3):410–2.

    Article  CAS  PubMed  Google Scholar 

  11. Saccone G, Louis C, Zhang H, Petrella V, Di Natale M, Perri M, et al. Male-specific phosphorylated SR proteins in adult flies of the Mediterranean fruitfly Ceratitis capitata. BMC Genetics. 2014;15 Suppl 2:S6.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Xu Q, Lee C. Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res. 2003;31(19):5635–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Sanford JR, Gray NK, Beckmann K, Cáceres JF. A novel role for shuttling SR proteins in mRNA translation. Genes Dev. 2004;18(7):755–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Fortes P, Longman D, McCracken S, Ip JY, Poot R, Mattaj IW, et al. Identification and characterization of RED120: a conserved PWI domain protein with links to splicing and 3′-end formation. FEBS Lett. 2007;581:3087–97.

    Article  CAS  PubMed  Google Scholar 

  15. Zhou A, Ou AC, Cho A, Benz Jr EJ, Huang SC. Novel splicing factor RBM25 modulates Bcl-x Pre-mRNA 5′ splice site selection. Mol Cell Biol. 2008;28(19):5924–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Gilkes DM, Saumendra B, Pallavi C, Denis W, Semenza GL. Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts. J Biol Chem. 2013;288(15):10819–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zhang K, Corsa CA, Ponik SM, Prior JL, et al. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat Cell Biol. 2013;15(6):677–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gilkes DM, Chaturvedi P. Collagen prolyl hydroxylases are essential for breast cancer metastasis. Cancer Res. 2013;73(11):3285–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Chakravarthi BV, Pathi SS, Goswami MT, et al. The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression. Oncotarget. 2014;5(16):6654–69.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Pan PW, Zhang Q, Bai F, Hou J, Bai G. Profiling and comparative analysis of glycoproteins in Hs578BST and Hs578T and investigation of prolyl 4-hydroxylase alpha polypeptide II expression and influence in breast cancer cells. Biochemistry (Mosc). 2012;77(5):539–45.

    Article  CAS  Google Scholar 

  21. Jarzab B, Wiench M, Fujarewicz K, Simek K, et al. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res. 2005;65(4):1587–97.

    Article  CAS  PubMed  Google Scholar 

  22. Chang KP, Yu JS, Chien KY, Lee CW, Liang Y, et al. Identification of PRDX4 and P4HA2 as metastasis associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology. J Proteome Res. 2011;10(11):4935–47.

    Article  CAS  PubMed  Google Scholar 

  23. Ridley AJ. Rho GTPases and actin dynamics in membrane pro-trusions and vesicle trafficking. Trends Cell Biol. 2006;16(10):522–9.

    Article  CAS  PubMed  Google Scholar 

  24. Kaneko M, Takeoka M, Oguchi M, Koganehira Y, et al. Calpon in hl suppresses tumor growth of src-induce d transformed 3Y1 cells in association with a de crease in angiogenesis. Jpn J Cancer Res. 2002;93(8):935–43.

    Article  CAS  PubMed  Google Scholar 

  25. Yanagisawa Y, Takeoka M, Ehara T, Itano N, Miyagawa S, Taniguchi S. Reduction of calponin H1 expression in human colon cancer blood vessels. Eur J Surg Oncol. 2008;34(5):531–7.

    Article  CAS  PubMed  Google Scholar 

  26. Ogura T, Kobayashi H, Ueoka Y, Okugawa K, Kato K, Hirakawa T, et al. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells. Clin Cancer Res. 2006;12(17):5216–23.

    Article  CAS  PubMed  Google Scholar 

  27. Hossain MM, Hwang D-Y, Huang Q-Q, Sasaki Y, Jin J-P. Developmentally regulated expression of calponin isoforms and the effect of h2-calponin on cell proliferation. Am J Physiol. 2003;284(1):156–67.

    Article  Google Scholar 

  28. Choi SY, Jang JH, Kim KR. Analysis of differentially expressed genes in human rectal carcinoma using suppression subtractive hybridization. Clin Exp Med. 2011;11(4):219–26.

    Article  CAS  PubMed  Google Scholar 

  29. Hossain MM, Hwang D-Y, Huang Q-Q, Sasaki Y, Jin J-P. Developmentally regulated expression of calponin isoforms and the effect of h2-calponin on cell proliferation. Am J Physiol. 2003;284(1):C156–67.

    Article  CAS  Google Scholar 

  30. Nagasawa A, Kubota R, Imamura Y, Nagamine K, et al. Cloning of the cDNA for a new member of the immunoglobulin superfamily (ISLR) containing leucine-rich repeat (LRR). Genomics. 1997;44(3):273–9.

    Article  CAS  PubMed  Google Scholar 

  31. D’Andrea LD, Regan L. TPR proteins: the versatile helix. Trends Biochem Sci. 2003;28(12):655–62.

    Article  PubMed  Google Scholar 

  32. Ishikawa Y, Wirz J, Vranka JA, Nagata K, Bächinger HP. Biochemical characterization of the prolyl 3-hydroxylase 1.cartilage-associated protein.cyclophilin B complex. J Biol Chem. 2009;284(26):17641–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Ahmad Mir S, Pavithra R, Jain AP, Khan AA, Datta KK, Mohan SV, et al. LC–MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma. J Proteomics. 2015;S1874-3919(15):00231–6.

    Google Scholar 

  34. Li C, Guo X, Jianqing Z, Yang M, Ge B, Li Z. Serum differential protein identification of Xinjiang Kazakh esophageal cancer patients based on the two-dimensional liquid-phase chromatography and LTQ MS. Mol Biol Rep. 2014;41(5):2893–905.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Funding

This study was supported by the grant from the National Natural Science Foundation of China, NO: 81260308, and the Open Subject about Xinjiang Major Diseases of China, NO: SKLIB-XJMDR-2014-12.

Author information

Author notes

    Authors and Affiliations

    1. Department of Pathology, First Affiliated Hospital, Xinjiang Medical University, Urumqi, 830054, China

      Feiyan Deng, Qiaoxin Li, Dong Liu, Hui Wang, Wei Zhang & Yuqing Ma

    2. Hypertension Center of the People’s Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang Uygur Autonomous Region, Urumuqi, Xinjiang, 830001, China

      Keming Zhou

    3. Department of Pathology, ZhunDong production worker hospital of Petro China Xinjiang oilfield company, Changji, Xinjiang, 831511, China

      Mengyan Li

    Authors
    1. Feiyan Deng
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Keming Zhou
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Qiaoxin Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Dong Liu
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Mengyan Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Hui Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Wei Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Yuqing Ma
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding authors

    Correspondence to Wei Zhang or Yuqing Ma.

    Additional information

    Feiyan Deng and Keming Zhou contributed equally to this work.

    Electronic supplementary material

    Below is the link to the electronic supplementary material.

    ESM 1

    (DOCX 30 kb)

    ESM 2

    (DOCX 30 kb)

    ESM 3

    (DOCX 22 kb)

    ESM 4

    (DOCX 91 kb)

    ESM 5

    (DOCX 147 kb)

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Deng, F., Zhou, K., Li, Q. et al. iTRAQ-based quantitative proteomic analysis of esophageal squamous cell carcinoma. Tumor Biol. 37, 1909–1918 (2016). https://doi.org/10.1007/s13277-015-3840-1

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s13277-015-3840-1

    Keywords

    Search

    Navigation